Nirvana Life Sciences (XCNQ:NIRV) LT-Debt-to-Total-Asset : 0.00 (As of Jan. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nirvana Life Sciences's long-term debt to total assests ratio for the quarter that ended in Jan. 2024 was 0.00.

Nirvana Life Sciences's long-term debt to total assets ratio stayed the same from Jan. 2023 (0.00) to Jan. 2024 (0.00).

Nirvana Life Sciences LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nirvana Life Sciences's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences LT-Debt-to-Total-Asset Chart

Nirvana Life Sciences Annual Data

Trend

Oct18

Oct19

Oct20

Oct21

Apr22

Apr23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Nirvana Life Sciences Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Nirvana Life Sciences LT-Debt-to-Total-Asset Calculation

Nirvana Life Sciences's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Apr. 2023 is calculated as

LT Debt to Total Assets (A: Apr. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Apr. 2023 )	/	Total Assets (A: Apr. 2023 )
	=	0	/	0.069
	=

Nirvana Life Sciences's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jan. 2024 is calculated as

LT Debt to Total Assets (Q: Jan. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Jan. 2024 )	/	Total Assets (Q: Jan. 2024 )
	=	0	/	0.212
	=

Nirvana Life Sciences (XCNQ:NIRV) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Nirvana Life Sciences LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nirvana Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8

Website

https://www.nirvanalifescience.com

Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences Headlines

No Headlines